A security vulnerability has been disclosed in the popular binary-parser npm library that, if successfully exploited, could result in the execution of arbitrary JavaScript. The vulnerability, tracked ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Abstract: In the field of supply chain, due to the involvement of multiple business entities, incomplete credit mechanism and information asymmetry have been the difficulties in supply chain that need ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The recursion depth limit in the descriptor parser is enforced after the full parse has already completed, which defeats its protective purpose. Specifically, the check is performed only after parser: ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

I'm two for two on writing about games set on the moon today, but sometimes that's just how it is! This time around it's about a newly revealed game called Descent of Lunaris, a dungeon-crawling, turn ...

Players aren’t simply fighting to survive another descent, they’re unraveling a mystery that asks difficult questions about the nature of humanity itself. Every floor deepens the uncertainty: are you ...